ArticlePloS one2012

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.

Charlotte Guyader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.